Previously, we reported that the streptomycin-treated mouse intestine selected nonmotile Escherichia coli MG1655 flhDC deletion mutants of E. coli MG1655 with improved colonizing ability that grow 15% faster in vitro in mouse cecal mucus and 15 to 30% faster on sugars present in mucus (M. P. Leatham et al., Infect. Immun. 73:8039 -8049, 2005). Here, we report that the 10 to 20% remaining motile E. coli MG1655 are envZ missense mutants that are also better colonizers of the mouse intestine than E. coli MG1655. One of the flhDC mutants, E. coli MG1655 ⌬flhD, and one of the envZ missense mutants, E. coli MG1655 mot-1, were studied further. E. coli MG1655 mot-1 is more resistant to bile salts and colicin V than E. coli MG1655 ⌬flhD and grows ca. 15% slower in vitro in mouse cecal mucus and on several sugars present in mucus compared to E. coli MG1655 ⌬flhD but grows 30% faster on galactose. Moreover, E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD appear to colonize equally well in one intestinal niche, but E. coli MG1655 mot-1 appears to use galactose to colonize a second, smaller intestinal niche either not colonized or colonized poorly by E. coli MG1655 ⌬flhD. Evidence is also presented that E. coli MG1655 is a minority member of mixed bacterial biofilms in the mucus layer of the streptomycin-treated mouse intestine. We offer a hypothesis, which we call the "Restaurant" hypothesis, that explains how nutrient acquisition in different biofilms comprised of different anaerobes can account for our results.
W hen a bacterial species indefinitely persists in stable numbers in the intestine of an animal, without repeated introduction, the animal is, by definition, colonized by the bacterium. Commensal Escherichia coli strains colonize the human intestine in the presence of a dense and diverse intestinal microbiota comprised of at least 500 cultivable species and 10 13 to 10 14 total bacteria (15) . Unfortunately, E. coli colonization cannot be studied experimentally in conventional animals due to colonization resistance, which results when all niches are filled by the microbiota (10) . Such experiments require an animal model with open niches for E. coli to colonize in relatively high numbers but must also have a dense and diverse anaerobic community that matches as closely as possible the native microbiota of the conventional animal. The streptomycin-treated mouse model is used routinely for this purpose (11, 34) .
In mammals, a large fraction of the intestinal microbiota belongs to either of two phyla, the Firmicutes and the Bacteroidetes (16, 37, 58) . Extensive microbiological characterization of the microbial community in the streptomycin-treated mouse intestine, published in the classic paper by Hentges et al. (28) , demonstrated that streptomycin treatment (5 mg/ml in drinking water) selectively removes the facultative anaerobes, with much less impact on the anaerobes. Streptomycin treatment does not alter the total numbers of Bacteroides (Bacteroidetes), Eubacterium (Firmicutes), Bifidobacterium (Actinobacteria), and Clostridium (Firmicutes), although there is a large decrease in Lactobacillus (Firmicutes) and Actinomyces (Actinobacteria) with a corresponding increase in Fusobacterium (Fusobacteria) and an apparent 50% decline in anaerobic species, as indicated by anaerobic colony morphologies (28) . In general, more recent studies using 16S rRNA gene sequencing confirmed these results (23, 58, 68) . It is now clear that any strategy to overcome colonization resistance will impact community structure (12, 57) . While the streptomycin-treated mouse model is not perfect, it allows competition of a variety of E. coli strains against a dense and diverse anaerobe population over extended time periods.
Previously, we found that when E. coli MG1655 was fed to streptomycin-treated mice, 80 to 90% of the population lacked flagella and became nonmotile within 7 to 9 days postfeeding (24, 36) . We showed that these nonmotile better colonizing mutants have deletions of various sizes beginning downstream of an IS1 element in the flhDC regulatory region and extending into or beyond the flhDC structural genes (24, 36) . FlhD and FlhC form the FlhD 4 C 2 complex (5, 40, 66) , which activates transcription of class II flagellar genes that encode components of the flagellar basal body and export machinery (51) . The IS1 element upstream of the E. coli MG1655 flhDC promoter increases expression of the flhDC operon and makes E. coli MG1655 hypermotile (4, 24) .
The flhDC deletion mutants selected by the streptomycintreated mouse intestine were found to grow faster than the parent strain in vitro in mouse cecal mucus and on sugars normally found in the mucus layer of the intestine (24, 36) , which presumably explains why they were selected. Additional studies suggested the E. coli MG1655 flhDC operon deletion mutants utilize sugars better than their parent because a number of metabolic genes are repressed by the FlhD 4 C 2 regulatory complex, including gltA (citrate synthase), sdhCDAB (succinate dehydrogenase), mdh (malate dehydrogenase), mglBAC (galactose transport), and a large number of sugar catabolism operons (20, 52, 53) . Also, increased energy is available for other cellular processes in the absence of hyper-flagellum synthesis and rotation (24) .
Despite the strong selection for nonmotile E. coli MG1655 flhDC deletion mutants by the streptomycin-treated mouse intestine, 10 to 20% of the E. coli MG1655 remained motile over a 15 day period (24) , suggesting either that they too were better colonizing mutants or that an as-yet-undefined intestinal niche exists in which motility is an advantage. Here, we report that the 10 to 20% of E. coli MG1655 that remain motile in the streptomycintreated mouse intestine are envZ missense mutants that display increased colonizing ability.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains used in the present study are listed in Table 1 . The original E. coli strain K-12 was obtained from a stool sample from a convalescing diphtheria patient in Palo Alto, CA, in 1922 (2) . The sequenced E. coli MG1655 strain (CGSC 7740) was derived from the original K-12 strain, having only been cured of the temperate bacteriophage lambda and the F plasmid by means of UV light and acridine orange treatment (2) . It has an IS1 element in the flhDC promoter (6) . The E. coli MG1655-IS1 strain used in the present investigation is isogenic to the MG1655 strain but lacks the IS1 element in the flhDC promoter (24) . The allelic-exchange method described by Datsenko and Warner (13) was used to construct E. coli MG1655 ⌬galK, which contains a 912-bp deletion, replaced by a chloramphenicol cassette beginning 153 bp downstream of the ATG start codon and ending 78 bp upstream of the TGA stop codon. As expected, the E. coli MG1655 mot-1 ⌬galK strain failed to grow in M9 minimal medium containing 0.4% (wt/vol) galactose as the sole carbon and energy source. E. coli MG1655 mot-1 ⌬galK was restored to Gal ϩ by allelic replacement (13) , selecting for restored growth on M9 minimal galactose agar plates. The restored Gal ϩ E. coli MG1655 mot-1 grew at the same rate as E. coli MG1655 mot-1 in M9 galactose minimal medium. The mutated envZ gene in E. coli MG1655 mot-1 was replaced with the wild-type envZ gene using an unpublished allelic replacement strategy developed by Barry Wanner and Kiryl Datsenko at Purdue University (unpublished data). The first step replaced the E. coli MG1655 mot-1 envZ/ompR locus with a cassette encoding kanamycin resistance (kan) and parE under the control of the rhamnose promoter (kan-rha P -parE). The parE gene encodes a DNA gyrase inhibitor, i.e., the toxin of a toxin anti/toxin pair that kills the cell when produced in the absence of its cognate antitoxin (31) . The second step replaced the kan-rha P -parE cassette with the wild-type envZ allele by selecting for growth on M9 minimal agar plates containing 1.0% (wt/vol) rhamnose (which would otherwise kill when rhamnose induces ParE). The double recombination event leaves no scars on the genome. All constructions were confirmed by sequencing.
Media and growth conditions. LB broth Lennox (Difco Laboratories, Detroit, MI), LB agar Lennox (Difco), and MacConkey agar (Difco) were used for routine cultivation. SOC medium was prepared as described by Datsenko and Wanner (13) . For testing carbon and energy source utilization, M9 minimal medium (44) was modified by addition of 120 mM NaCl to more closely approximate the sodium chloride concentration in the intestine (3) . Growth also was tested in cecal mucus (2.5 mg of protein/ml) in HEPES-Hanks buffer (pH 7.0), which contains 137 mM NaCl, the sodium chloride concentration in jejunal and ileal intestinal fluid (3). Cultures were prepared, and growth was monitored as described previously (36) .
Isolation of cecal mucus. Mouse cecal mucus was isolated as previously described (9) . Briefly, mice (5 to 8 weeks old) were fed Teklad mouse and rat diet (Harlan Laboratories, Madison, WI) for 5 days after being received. The drinking water was then replaced with sterile distilled water containing streptomycin sulfate (5 g/liter). After 24 h, the mice were sacrificed by CO 2 asphyxiation, and their ceca were removed. The cecal contents were washed out with sterile distilled water, and the cecal mucus was scraped into HEPES-Hanks buffer (pH 7.0), centrifuged, and sterilized by UV irradiation as described previously (9) . All animal protocols were (3) . The plates were incubated for 6 h at 37°C, after which spreading was measured from the edge of each colony. For testing the motility of fecal isolates, 50 colonies from fecal platings of each mouse were toothpicked to motility agar made from LB broth Lennox containing 85.5 mM NaCl. The plates were incubated overnight at room temperature. For testing motility of bacteria from intestinal segments, the ileum, cecum, and colon were removed from each mouse and washed extensively with HEPES-Hanks buffer (pH 7.0), and the mucus was scraped into 5 ml of HEPES-Hanks buffer (pH 7.0), as described previously (9) . Samples were homogenized by vortexing, plated on Mac-Conkey agar with appropriate antibiotics, and toothpicked onto motility agar, as described above for fecal isolates.
Growth in the presence of 5% bile salts. Strains to be tested for bile sensitivity were grown overnight in LB broth Lennox, diluted to an A 600 of ϳ0.1 into fresh LB broth Lennox containing 5% (wt/vol) Bacto-Bile Salts No. 3 (Difco Laboratories), and incubated at 37°C with shaking in 125-ml tissue culture bottles.
Mouse colonization experiments. The specifics of the streptomycintreated mouse model used to compare the large intestine colonizing abilities of E. coli strains in mice have been described previously (42, 47, 59, 60, 65) . Briefly, sets of three male CD-1 mice (5 to 8 weeks old) were given drinking water containing streptomycin sulfate (5 g/liter) for 24 h to eliminate resident facultative bacteria (43) . After 18 h of starvation for food and water, the mice were fed 1 ml of 20% (wt/vol) sucrose containing 10 5 CFU or 10 10 CFU of LB broth Lennox-grown E. coli strains, as described in Results. After ingesting the bacterial suspension, both the food (Teklad mouse and rat diet; Harlan Laboratories) and streptomycin-water were returned to the mice, and 1 g of feces was collected after 5 h, 24 h, and on odd-numbered days thereafter at the indicated times. Mice were housed individually in cages without bedding and were placed in clean cages at 24-h intervals. Individual fecal pellets were therefore no older than 24 h. Each fecal sample (1 g) was homogenized in 10 ml of 1% Bacto tryptone (Difco), diluted in the same medium, and plated on MacConkey agar plates with appropriate antibiotics. When appropriate, 1 ml of a fecal homogenate (sampled after the feces had settled) was centrifuged at 12,000 ϫ g, resuspended in 100 l of 1% Bacto tryptone, and plated on a MacConkey agar plate with the appropriate antibiotics. This procedure increases the sensitivity of the assay from 10 2 CFU/gram of feces to 10 CFU/per g of feces. To distinguish the various E. coli strains in feces, dilutions were plated on lactose MacConkey agar containing either streptomycin sulfate (100 g/ml), streptomycin sulfate (100 g/ml) and nalidixic acid (50 g/ml), or streptomycin sulfate (100 g/ml) and chloramphenicol (30 g/ml). Streptomycin sulfate, chloramphenicol, and nalidixic acid were purchased from Sigma-Aldrich (St. Louis, MO). All plates were incubated for 18 to 24 h at 37°C prior to counting. When necessary to distinguish strains, 100 colonies from plates containing streptomycin were toothpicked onto MacConkey agar plates containing streptomycin and nalidixic acid or onto MacConkey agar plates containing streptomycin and chloramphenicol. Each colonization experiment was performed at least twice, with essentially identical results. Pooled data from at least two independent experiments (a total of six mice) are presented in the figures.
Sequencing. DNA sequencing was done at the URI Genomics and Sequencing Center, University of Rhode Island, Kingston, using an Applied Biosystems 3130xl genetic analyzer (Applied Biosystems, Foster City CA). A BigDye Terminator v3.1 cycle sequencing kit (Applied Biosystems) was used in the sequencing reactions. The primers used to amplify the PCR product (2,241 bp) for sequencing the ompB locus included the forward primer (upstream of ompR) 5=-TAGCTGGTGACGAACGTGA G-3= and the reverse primer (downstream of envZ) 5=-GTAGCGGCTGG TCCGAA-3=. The same primers, as well as 5=-ATCCTGCTCGCTCATCA TC-3=, which begins 565 bp from the 3= end of envZ, were used in the sequencing reactions. The primers used for both amplifying the galK deletion for allelic exchange and for sequencing to confirm its presence in E. coli MG1655 mot-1 ⌬galK were the forward primer (43 bp upstream of the galK coding sequence) 5=-AACAGGCAGCAGAGCGTTTGC-3= and the reverse primer (53 bp downstream of the galK coding sequence) 5=-AGT CCATCAGCGTGACTACCATC-3=. The primers used for the replacement of the ⌬galK mutation with wild type were the forward primer (44 bp upstream of the galK start codon) 5=-AACAGGCAGCAGAGCGTTT GC-3= and the reverse primer (68 bp downstream of the galK stop codon) 5=-AGTCCATCAGCGTGACTACCATC-3=. The primers used for confirming the restoration of the wild-type galK gene sequence are the same as those used for restoring the wild-type sequence.
Colicin V sensitivity. E. coli F-18 produces colicin V (42) . E. coli MG1655 strains to be tested for sensitivity to colicin V were grown overnight in LB broth Lennox at 37°C with shaking in 125-ml tissue culture bottles. The next day, 10 6 CFU of each strain to be tested was added to 3 ml of Luria broth Lennox containing 7 g Difco agar (soft agar)/liter, which was then poured onto a 20-ml Luria broth Lennox agar plate. After the soft agar on each plate solidified, E. coli F-18 colonies were toothpicked onto each plate and incubated for 18 h at 37°C, and zones of growth inhibition were measured.
Fluorescence in situ hybridization. The preparation of mouse cecal histological sections, the oligonucleotide probes, hybridization, and confocal microscopy were all as described previously (46) .
Statistics. Means derived from the indicated number of samples were compared by using the Student t test (P values). A P value of Ͼ0.05 was interpreted as indicating no significant difference, and a P value of Ͻ0.05 was interpreted as indicating a significant difference.
RESULTS

Isolation of E. coli MG1655 mot-1, mot-2, and mot-3 from the mouse intestine.
Previously, we showed that despite the strong selection for nonmotile E. coli MG1655 flhDC deletion mutants by the streptomycin-treated mouse intestine, 10 to 20% of the E. coli MG1655 cells remained motile over a 15-day period (36) . To determine the nature of the population that remained motile, three mice were fed 10 10 CFU of E. coli MG1655 and 10 5 CFU of E. coli MG1655 ⌬flhD. At 5 h and day 1 postfeeding, the level of E. coli MG1655 ⌬flhD in feces was ϳ5 orders of magnitude lower than E. coli MG1655, but by day 7 E. coli MG1655 ⌬flhD had grown to a population of only 1.5 orders of magnitude lower than E. coli MG1655 and remained at that level thereafter for the 15 days of the experiment (Fig. 1A) . As a control, mice were fed 10 10 CFU of E. coli MG1655 ⌬flhD and 10 5 CFU of E. coli MG1655. As expected, the better colonizing E. coli MG1655 ⌬flhD completely eliminated E. coli MG1655 within 3 days postfeeding ( Fig. 1B) . At day 15, the mice fed high numbers of E. coli MG1655 and low numbers of E. coli MG1655 ⌬flhD ( Fig. 1A) were sacrificed, and the numbers of E. coli MG1655 and E. coli MG1655 ⌬flhD in ileal mucus, cecal mucus, and colonic mucus were determined. In each mucus preparation, the numbers of E. coli MG1655 ⌬flhD were 1.5 to 2 orders of magnitude lower than E. coli MG1655, reflecting the results observed in feces ( Table 2 ). Although less than 1 in 6,300 CFU of the E. coli MG1655 fed to the mice were nonmotile (24) and less than 1 in 100 CFU in feces were nonmotile at both 5 h and 1 day postfeeding, by day 3 postfeeding 17% Ϯ 7.9% (mean Ϯ the SEM) in feces were nonmotile, by day 7 postfeeding 65% Ϯ 15% in feces were nonmotile, by day 13 postfeeding 75% Ϯ 18% in feces were nonmotile, and on day 15 postfeeding 76% Ϯ 13% in feces were nonmotile. Therefore, despite competition from the better-colonizing E. coli MG1655 ⌬flhD and the selection by the intestine of nonmotile E. coli MG1655, ca. 25% of the E. coli MG1655 remained motile within each section of the intestine. On day 13 postfeeding, 1 motile E. coli MG1655 colony was selected from the feces of each mouse for further study. These strains were designated E. coli MG1655 mot-1, mot-2, and mot-3, respectively.
E. coli MG1655 mot-1, mot-2, and mot-3 are envZ missense mutants. E. coli MG1655 mot-1, mot-2, and mot-3 were less motile than the hypermotile E. coli MG1655 (Table 3) . Previously, we reported that when the IS1 element was removed from the flhDC regulatory region of E. coli MG1655, the resulting strain, E. coli MG1655-IS1, was a better colonizer and remained motile, although far less so than its parent (24) . However, E. coli MG1655 mot-1, mot-2, and mot-3 retained the IS1 element, as determined by PCR (data not shown).
Giraud et al. reported that when germfree mice were fed E. coli MG1655, the mouse intestine selected better-colonizing, less-motile E. coli MG1655 mutants that contained point mutations in the envZ-ompR locus (25) . EnvZ, a histidine kinase, and OmpR, its cognate response regulator, comprise a two-component signal transduction system that modulates gene expression in response to osmolarity (17) . When we sequenced the envZ and ompR genes of the three mot mutants-E. coli MG1655 ⌬flhD, E. coli MG1655-IS1, and E. coli MG1655-we found that the ompR sequences of the six strains were identical, as were the envZ sequences of E. coli MG1655 ⌬flhD, E. coli MG165-IS1, and the wild-type E. coli MG1655. Importantly, E. coli MG1655 mot-1, mot-2, and mot-3 were found to be envZ missense mutants: mot-1 a P41L mutant (CCG to CTG) in the N-terminal transmembrane domain, mot-2 a P148S mutant (CCG to TCG) in the periplasmic osmolarity sensing domain, and mot-3 a V33E mutant (GTG to GAG) in the N-terminal transmembrane domain (21, 69) . That the envZ missense mutation in mot-1 was responsible for reduced motility was shown by the fact that when E. coli MG1655 mot-1 was restored to the wild type with respect to envZ, it regained hypermotility ( Table 3) .
The E. coli mot mutants are resistant to bile salts and colicin V. Among the many activities controlled by the two component EnvZ/OmpR signal transduction system are transcription of ompF and ompC, which encode E. coli outer membrane porins that allow passage of many small molecules (Յ600 Da) from the environment into the periplasm (1). Bile salts, which are present in the human small intestine at a concentration of ca. 0.3% (64) and can inhibit E. coli growth at 5% concentration in vitro (25) , pass readily through the OmpF porin but much less so through the OmpC porin (62) . High levels of OmpRϳP downregulate tran- scription of ompF and upregulate transcription of ompC, resulting in decreased OmpF and increased OmpC in the outer membrane (55) . The E. coli MG1655 envZ missense mutants described by Girard et al. as being selected in germfree mice monoassociated with E. coli MG1655 were reported to have decreased OmpF and increased OmpC and were found to be more resistant to 5% bile salts than their parent (25) , suggesting that the envZ mutants had higher levels of OmpRϳP than E. coli MG1655. Here, we report that E. coli MG1655 mot-1, mot-2, and mot-3 are far more resistant to 5% bile salts than E. coli MG1655, E. coli MG1655 ⌬flhD, and an E. coli MG1655 mot-1 strain restored to wild type ( Fig. 2A  and 2B ). It should also be noted that the E. coli MG1655 and E. coli MG1655 ⌬flhD strains are still relatively resistant to bile salts, i.e., their growth is unaffected by 0.3% bile salts (data not shown), the concentration reported to be present in the human small intestine (64) . In addition to regulating ompF and ompC, the EnvZ/OmpR signal transduction system also positively regulates the transcription of omrA and omrB, which encode two small RNAs that negatively regulate the expression of a number of outer membrane proteins, including CirA, the receptor for colicin V (7) . Since it appeared likely that the E. coli MG1655 mot mutants have higher than normal levels of OmpRϳP, it seemed possible that they would have lower levels of CirA in the outer membrane and therefore be more resistant to the action of colicin V. Indeed, E. coli F-18, which produces colicin V (44), inhibited the growth of E. coli MG1655 (zone of inhibition, 2.01 Ϯ 0.11 mm [n ϭ 8]), E. coli MG1655 ⌬flhD (zone of inhibition, 2.03 Ϯ 0.11 mm [n ϭ 8]), and E. coli MG1655 mot-1 restored to wild type (zone of inhibition, 1.98 Ϯ 0.21 mm [n ϭ 8]) to a greater extent than it inhibited the growth of E. coli MG1655 mot-1 (zone of inhibition, 0.40 Ϯ 0.07 mm [n ϭ 8]), E. coli MG1655 mot-2 (zone of inhibition, 0.53 Ϯ 0.13 mm [n ϭ 8]), and E. coli MG1655 mot-3 (zone of inhibition, 0.31 Ϯ 0.08 mm [n ϭ 8]) (P Ͻ 0.0005 in each case), suggesting that the mot mutants have less-than-normal levels of CirA in their outer membranes. Furthermore, since omrA and omrB also negatively regulate expression of a number of other outer membrane proteins (26) , such as CsgD (regulator of Curli biosynthesis), it is likely that the outer membranes of the E. coli MG1655 mot mutants differ markedly from those of E. coli MG1655 and E. coli MG1655 ⌬flhD.
E. coli MG1655 mot-1 is a better mouse intestinal colonizer than E. coli MG1655 and equal to E. coli MG1655 ⌬flhD. The P41L replacement in EnvZ previously was shown to result in higher than normal levels of OmpRϳP in E. coli AT142 (63) . We therefore chose to study E. coli MG1655 mot-1 in more detail since it has the same envZ missense mutation. We found that when 10 5 CFU each of E. coli MG1655 mot-1 and E. coli MG1655 were fed to mice simultaneously, E. coli MG1655 mot-1 colonized at a level of ϳ10 9 CFU per g of feces, whereas E. coli MG1655 colonized at a level of between 10 5 and 10 6 CFU per g of feces (Fig. 3A) . The enhanced colonization of E. coli MG1655 mot-1 could be specifically attributed to the P41L replacement in EnvZ, since E. coli MG1655 mot-1 restored to wild type and E. coli MG1655 cocolonized at equal population sizes (data not shown). Moreover, E. coli MG1655 mot-1 was as good a colonizer as E. coli MG1655 ⌬flhD (Fig. 3B) . Therefore, E. coli MG1655 mot-1 is a far better colonizer than E. coli MG1655 wild type and as competitive as E. coli MG1655 ⌬flhD, which explains why the mot-1 strain can remain in the intestine at high levels despite conversion of the majority of the wild-type E. coli MG1655 to the ⌬flhD genotype with its superior colonization phenotype.
Growth of E. coli MG1655 mot-1 on sugars in vitro. To address the question of whether E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD are equally good colonizers because they grow equally well on sugars present in the mouse intestine, experiments were performed to compare the growth rates of E. coli MG1655 mot-1, E. coli MG1655 ⌬flhD, and E. coli MG1655 on a variety of sugars as the sole source of carbon and energy. E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD did not grow equally well on all of the sugars tested. In fact, E. coli MG1655 mot-1 grew 30% faster than E. coli MG1655 ⌬flhD on galactose (P Ͻ 0.0005) and 5% faster on N-acetylglucosamine (P Ͻ 0.01) but grew slower than E. coli MG1655 ⌬flhD on arabinose (15%, P Ͻ 0.005), fucose (14%, P Ͻ 0.01), glucose (10%, P Ͻ 0.01), maltose (27%, P Ͻ 0.001), and mannose (5%, P Ͻ 0.025) and at the same rate as E. coli MG1655 ⌬flhD on fructose (P ϭ 0.15), gluconate (P Ͼ 0.2), and ribose (P Ͼ 0.05) (Table 4 ). Also, E. coli MG1655 mot-1 grew faster than E. coli MG1655 on fructose (16%, P Ͻ 0.01), galactose (34%, P Ͻ 0.0005), gluconate (11%, P Ͻ 0.005), mannose (9%, P Ͻ 0.05), and N-acetylglucosamine (21%, P Ͻ 0.001), slower than E. coli MG1655 on maltose (12%, P Ͻ 0.005), and at the same rate as E. coli MG1655 on arabinose (P Ͼ 0.10), fucose (P Ͼ 0.10), glucose (P Ͼ 0.05), and ribose (P Ͼ 0.05) ( Table 4 ). In addition, E. coli MG1655 ⌬flhD grew 4 to18% faster than E. coli MG1655 on all of the sugars tested as the sole carbon and energy sources (P Ͻ 0.01 to Ͻ 0.0005 depending on the sugar) except for galactose, on which the two strains grew equally well (P Ͼ 0.15) ( Table 4 ). That the 34% faster growth rate of E. coli MG1655 mot-1 on galactose relative to wild-type E. coli MG1655 was due to the P41L mutation in EnvZ was shown by the fact that the growth rates of E. coli MG1655 mot-1 restored to wild type and E. coli MG1655 on galactose were identical (P Ͼ 0.15) ( Table 4) .
Growth of E. coli MG1655 mot-1 in cecal mucus in vitro. E. coli MG1655 simultaneously metabolizes a number of sugars when it colonizes the streptomycin-treated mouse intestine (8, 19) . That E. coli MG1655 mot-1 grew slower than E. coli MG1655 ⌬flhD on arabinose, fucose, and maltose, three sugars used by E. coli MG1655 for growth in the mouse intestine (8, 19, 33) , but faster on galactose and N-acetylglucosamine could explain why E. coli MG1655 mot-1 colonizes mice as well as E. coli MG1655 ⌬flhD. Since E. coli colonizes the intestine by growing in intestinal mucus (39, 45, 46, 48, 59, 60, 65) , which contains at least 13 different monosaccharides that can be used by E. coli, we examined the growth rates of E. coli MG1655 mot-1, the E. coli MG1655 mot-1 strain restored to wild type, E. coli MG1655, and E. coli MG1655 ⌬flhD in mouse cecal mucus standing cultures (2.5 mg/ml with respect to protein). Under these conditions, E. coli MG1655 mot-1 grew ca. 15% slower than E. coli MG1655 ⌬flhD (P Ͻ 0.025) but at about the same rate as E. coli MG1655 (P Ͼ 0.15) and E. coli MG1655 mot-1 restored to wild type (P ϭ 0.50) ( Table 5 ). Therefore, the differences in growth rates of the strains in cecal mucus do not reflect their relative colonizing abilities, i.e., E. coli MG1655 mot-1 ϭ E. coli MG1655 ⌬flhD Ͼ E. coli MG1655 (Fig. 3 ).
E. coli MG1655 mot-1 resides in all intestinal niches occupied by E. coli MG1655 ⌬flhD. Although low numbers of E. coli
MG1655 ⌬flhD grew to higher numbers in the presence of high numbers of E. coli MG1655 in the mouse intestine ( Fig. 1) , it did not grow up relative to E. coli MG1655 mot-1, i.e., the two strains, fed to mice in numbers 5 orders of magnitude apart, remained 5 to (Fig. 4B) . Therefore, it is likely that high numbers of E. coli MG1655 mot-1 prevented low numbers of E. coli MG1655 ⌬flhD from growing to higher numbers because E. coli MG1655 mot-1 resides in and competes effectively in all intestinal niches occupied by E. coli MG1655 ⌬flhD. E. coli MG1655 does not use galactose to colonize the streptomycin-treated mouse intestine, i.e., an E. coli MG1655 ⌬galK mutant that is unable to grow on galactose as a sole carbon source cocolonizes equally well with E. coli MG1655 wild type in the streptomycin-treated mouse intestine (19) . However, it appears that the ability of E. coli MG1655 mot-1 to grow 30% faster on galactose than E. coli MG1655 ⌬flhD contributes in part to it preventing low numbers of E. coli MG1655 ⌬flhD from growing to higher numbers. When E. coli MG1655 ⌬flhD was fed to mice at 5 orders of magnitude lower than E. coli MG1655 mot-1 ⌬galK, it colonized at a level 4 orders of magnitude lower (Fig. 4C) , rather than the 5 to 6 orders of magnitude lower in competition with E. coli MG1655 mot-1 (Fig. 4A ) or E. coli MG1655 mot-1 ⌬galK restored to wild type with respect to galK (data not shown). It should be emphasized, however, that E. coli MG1655 mot-1 ⌬galK still prevented E. coli MG1655 ⌬flhD from growing to a level any higher than 4 orders of magnitude below it, despite growing 25% slower than E. coli MG1655 mot-1 in cecal mucus in vitro (P Ͻ 0.01) ( Table 5 ).
E. coli MG1655 mot-1 may colonize an intestinal niche that E. coli MG1655 ⌬flhD colonizes poorly. That E. coli MG1655 mot-1 resides in all intestinal niches occupied by E. coli MG1655 ⌬flhD does not mean E. coli MG1655 ⌬flhD resides in all intestinal niches occupied by E. coli MG1655 mot-1. Since E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD are equally good colonizers when 10 5 CFU of each is fed to mice (Fig. 3C ) and since high numbers of E. coli MG1655 mot-1 prevent low numbers of E. coli MG1655 ⌬flhD from growing to high numbers in the intestinal niches they occupy together (Fig. 4A) , it would be expected that if E. coli MG1655 ⌬flhD resides in all intestinal niches occupied by E. coli MG1655 mot-1 that high numbers of E. coli MG1655 ⌬flhD would prevent low numbers of E. coli MG1655 mot-1 from growing to higher numbers in the streptomycin-treated mouse intestine. To test that possibility, mice were fed 10 10 CFU of E. coli MG1655 ⌬flhD and 10 5 CFU of E. coli MG1655 mot-1. Surprisingly, E. coli MG1655 mot-1 grew from about 5 orders of magnitude lower than E. coli MG1655 ⌬flhD to within 2 orders of magnitude of E. coli MG1655 ⌬flhD by 9 days postfeeding (Fig. 5A) . Therefore, it appears that E. coli MG1655 mot-1 not only resides in all the intestinal niches occupied by E. coli MG1655 ⌬flhD but may also colonize a smaller niche that E. coli MG1655 ⌬flhD is unable to colonize or colonizes poorly. Moreover, it appears that E. coli MG1655 mot-1 uses its superior ability to metabolize galactose to colonize that niche, since low numbers of E. coli MG1655 mot-1 ⌬galK failed to grow to higher numbers in the presence of high numbers of E. coli MG1655 ⌬flhD (Fig. 5B) , whereas low numbers of E. coli MG1655 mot-1 ⌬galK restored to wild type with respect to galactose utilization grew to higher numbers (data not shown). To summarize, E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD appear to colonize one intestinal niche equally well and E. coli MG1655 mot-1 appears to need galactose for maximum growth in that niche. In addition, it appears that E. coli MG1655 mot-1 also uses galactose to colonize a second smaller intestinal niche that E. coli MG1655 ⌬flhD either fails to colonize or colonizes poorly. E. coli MG1655 forms mixed biofilms in the mouse intestine. Commensal E. coli strains colonize the streptomycin-treated mouse intestine by growing in the intestinal mucus layer of the large intestine (39, 45, 46, 48, 59, 60, 65) . It has recently become clear that biofilms form in the mucus layers of the large intestines of humans, rats, baboons, and mice (49, 61) and that mixed biofilms consisting of bacteroides, enterobacter, and clostridium species form rapidly on strands of mucin in mucus introduced into a growing human microbiota contained in a continuous flow culture system constructed to mimic the human intestine (41) . Moreover, the kinetics of plasmid transfer between E. coli strains in the streptomycin-treated mouse intestine suggests that E. coli resides in biofilms in vivo (38) . Previously, we reported that E. coli MG1655 is found in cecal mucus dispersed as either single cells or dividing doublets among other members of the microbiota at 24 h postfeeding (45, 46) ; however, in view of the recent data on biofilm formation in the mammalian intestine, we wondered whether dense microbial communities containing E. coli MG1655 might form in the streptomycin treated mouse intestine at later times. As shown previously and in Fig. 6A, at 24 h postfeeding E. coli MG1655 appeared to be randomly dispersed and yet closely associated with other members of the microbiota in the cecal mucus layer; however, at 48 h postfeeding, although E. coli MG1655 remained mostly as single cells or as doublets, they appeared to be minority members of dense mixed biofilms ( Fig. 6B) . At neither 24 h nor 48 h postfeeding was E. coli MG1655 found to be associated with the epithelium (Fig. 6) .
DISCUSSION
Previously, we reported that the streptomycin-treated mouse intestine selects nonmotile E. coli MG1655 flhDC deletion mutants that have improved colonizing ability (24, 36) . These mutants grew 15% faster than their parent in mouse cecal mucus in vitro and 15 to 30% faster on several sugars found in the mouse intestine, suggesting that their better colonizing ability was due to their more efficient utilization of sugars for growth (36) . In our previous studies, despite the strong selection for nonmotile flhDC deletion mutants, 10 to 20% of the E. coli MG1655 cells remained motile (24) . In the present study, we demonstrate that these motile E. coli MG1655 contain missense mutations in envZ that make them less motile and better colonizers than wild-type E. coli MG1655 and more resistant to bile salts and colicin V than E. coli MG1655 and E. coli MG1655 ⌬flhD, suggesting that they have higher levels of OmpRϳP. Among the many activities controlled by EnvZ/OmpR is tran- MG1655 mot-1 restored to wild type, E. coli MG1655 mot-1 ⌬galK, and E. coli MG1655 ⌬flhD. Two sets of three mice were fed 10 10 CFU of E. coli MG1655 mot-1 Str r (OE) and 10 5 CFU of MG1655 Str r ⌬flhD::cat () (A); two sets of three mice were fed 10 10 CFU of E. coli MG1655 mot-1 Str r restored to wild type (OE) and 10 5 CFU of E. coli MG1655 Str r ⌬flhD::cat () (B); and three sets of three mice were fed 10 10 CFU of E. coli MG1655 mot-1 Str r ⌬galK () and 10 5 CFU of E. coli MG1655 Str r ⌬flhD::cat () (C). At the indicated times, fecal samples were homogenized, diluted, and plated as described in Materials and Methods. When necessary, i.e., to distinguish strains, 100 colonies from plates containing streptomycin were toothpicked onto MacConkey agar plates containing streptomycin and chloramphenicol. Bars represent standard errors of the log 10 means of CFU per g of feces. Enhanced Colonization of E. coli envZ Mutants scription of the flhDC operon, i.e., OmpRϳP is a negative regulator of the operon in E. coli strains that lack the IS1 element in the flhDC promoter (56) . Such strains are not hypermotile and become even less motile at higher medium osmolarity because the level of OmpRϳP under these conditions is sufficient to further repress the flhDC operon (4, 24) . In contrast, E. coli MG1655, which contains the IS1 element in the flhDC promoter, remains hypermotile under high-osmolarity conditions (4, 24) , suggesting the possibility that the IS1 element reduces the affinity of OmpRϳP for the OmpR binding sites in the flhDC promoter. The fact that the E. coli MG1655 envZ missense mutants are far less motile than E. coli MG1655 (Table 3 ) suggests that the even higher level of OmpRϳP in these mutants allows some level of binding to the OmpR binding sites in the flhDC regulatory region, resulting in less transcription of the operon and consequently less FlhD 4 C 2 , despite the presence of the IS1 element. Also, since FlhD 4 C 2 represses a number of sugar catabolism operons (20) , less FlhD 4 C 2 in E. coli MG1655 mot-1 than in E. coli MG1655 but more than in E. coli MG1655 ⌬flhD would be consistent with it growing faster than E. coli MG1655 on a number of sugars and slower than E. coli MG1655 ⌬flhD on a number of sugars, as we observed (Table 4) . Although E. coli MG1655 mot-1 grew slower than E. coli MG1655 ⌬flhD on several sugars, it did grow ca. 30% faster than E. coli MG1655 ⌬flhD and E. coli MG1655 on galactose in vitro (Table 4). In this regard, it is interesting that there is a putative OmpR binding site upstream of the galR promoter between galR and omrB (26) . GalR is the major repressor of both galactose transport and catabolism (67) . Although it is known that OmpRϳP positively regulates transcription of omrB (26), it is not known whether it also negatively regulates galR transcription. Negative regulation of galR transcription by increased levels of OmpRϳP in E. coli MG1655 mot-1 could explain why it grows faster than E. coli MG1655 and E. coli MG1655 ⌬flhD on galactose as the sole source of carbon and energy. Giraud et al. (25) demonstrated that when germfree mice were fed the same wild-type E. coli MG1655 strain as used here, the mouse intestine selected better-colonizing, less-motile E. coli MG1655 envZ missense mutants. More recently, De Paepe et al. (14) demonstrated that several days after the envZ missense mutants reached maximum numbers in germfree mice monoassoci-ated with E. coli MG1655, mutants with flhDC deletions appeared and increased in numbers thereafter, showing that the monoassociated mouse intestine can select E. coli MG1655 flhDC deletion mutants in the presence of high numbers of E. coli MG1655 envZ missense mutants. Interestingly, our data show that the monoassociated ex-germfree mouse intestine and the streptomycintreated mouse intestine are different in this regard: flhDC mutants would not be selected after envZ missense mutants reach maximum numbers in the streptomycin-treated mouse intestine since in this model high numbers of an E. coli MG1655 envZ missense mutant prevented growth of an E. coli MG1655 flhDC deletion mutant from lower to higher numbers (Fig. 4A) .
It was also demonstrated by De Paepe et al. (14) that their in vivo results could be reproduced in chemostats containing 0.8% bile salts, a concentration reasonable for the intestine of a germfree mouse (18) , but ϳ2.7-fold higher than the 0.3% concentration of bile salts reported to be in the human small intestine (64) . In fact, the presence of a conventional microbiota decreases the concentration of bile salts in the mouse intestine, i.e., in the conventional mouse cecum and colon the concentration of bile salts is known to be ϳ2.5-fold lower than in the germfree mouse cecum and colon (18) . It is therefore unlikely that bile salts play as much of a role in E. coli MG1655 colonization of the streptomycintreated mouse intestine, which contains a large and diverse microbiota, as they do in its colonization of the monoassociated mouse intestine. In support of this view, despite E. coli MG1655 ⌬flhD being more sensitive to bile salts than E. coli MG1655 mot-1, the two strains grew equally well from low to high numbers in the streptomycin treated mouse intestine when 10 5 CFU each of the two strains were fed to mice simultaneously (Fig. 3B) . It therefore appears likely that the differences between our results and those of De Paepe et al. (14) reflect physical and nutritional interaction of the E. coli MG1655 strains with other members of the complex microbial community present in the streptomycintreated mouse intestine but absent in the monoassociated, formerly germfree mouse intestine.
The concept that nutrient availability dictates the community structure of the intestine was originally presented in Freter's nutrient-niche hypothesis, which states that species coexist in the intestine because each is able to grow faster than all others on one or a few limiting nutrients and that the rate of growth of each species during the colonization process is at least equal to its washout rate from the intestine (22) . The hypothesis assumes that all nutrients are perfectly mixed and that they are equally available to all species present in the intestine. According to the hypothesis, two strains cannot coexist in the intestine when one competes less well than the other for the same nutrient(s) unless the metabolically less efficient one adheres to the intestinal wall (22) . Adhesion of a bacterium to the intestinal wall is not restricted to the epithelium, it could, for example, also be achieved by adhesion of that bacterium to mucin strands in the outer loose mucus layer where commensal strains reside (32, 50) that might be anchored in the relatively bacteria-free inner dense mucus layer or, alternatively by attachment to other members of the microbiota that adhere to mucin strands in the outer loose mucus layer. In either case, such attachment could delay the metabolically less efficient strain from being washed out as the loose mucus layer at the luminal surface is sloughed into luminal contents and eliminated in feces.
We found no evidence that E. coli MG1655 adheres to the intestinal epithelium but did find that it binds to other members of the microbiota as a minority member of mixed biofilms in cecal mucus (Fig. 6B ). We also found that E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD each use some sugars for growth better than the other in vitro (Table 4 ) and that they cocolonize the mouse intestine equally well when equal numbers of each strain are fed to mice (Fig. 3B) , indicating that sufficient levels of the sugars that each strain uses better are available to each strain when they cocolonize. As such, it would be expected according to the nutrientniche hypothesis that low numbers of each strain would be able to grow to higher numbers in the intestine in the presence of high numbers of the other strain. Indeed, by using its superior ability to grow on galactose, low numbers of E. coli MG1655 mot-1 grew to higher numbers in the presence of high numbers of E. coli MG1655 ⌬flhD (Fig. 5A ). However, contrary to expectations, high numbers of E. coli MG1655 mot-1 prevented low numbers of E. coli MG1655 ⌬flhD from growing to higher numbers (Fig. 4A) . Below we outline a modified version of the Freter nutrient-niche hypothesis to explain our results based on the finding that E. coli MG1655 appears to reside in mixed biofilms in the streptomycintreated mouse intestine.
Mono-and disaccharides and maltodextrins are absorbed in the small intestine, whereas dietary fiber reaches the large intestine intact. In contrast to the anaerobes (29), E. coli does not secrete extracellular polysaccharide hydrolases (27, 30) and therefore cannot degrade dietary fiber-derived and mucin-derived oligoand polysaccharides. Commensal E. coli strains colonize the mouse large intestine by growing in intestinal mucus (39, 45, 46, 48, 59, 60, 65) . It therefore appears likely that E. coli depends on the anaerobes present in mucus that can degrade oligo-and polysaccharides to provide them with the mono-and disaccharides they need for growth. We hypothesize that the anaerobes in the mixed biofilms inhabited by E. coli provide them with mono-and disaccharides locally, rather than from a perfectly mixed pool available to all species, which is an assumption of the nutrientniche hypothesis. We further hypothesize that one strain of E. coli can have a higher affinity for binding sites on mixed biofilms than a second strain due to differences between the outer surfaces of the two strains. In addition, we hypothesize that E. coli cells that detach from a mixed biofilm either spontaneously or through repli-cation and hence free in mucus are not exposed to mono-and disaccharides because those sugars are produced and used locally within the mixed biofilms and are therefore not available to detached E. coli cells. Consequently, E. coli cells not attached to a mixed biofilm will not grow or will grow slower than the washout rate and will be eliminated in feces unless they bind to and become part of other mixed biofilms that are constantly forming in the mucus layer.
How does the hypothesis account for our results? Our results suggest that the outer membranes of E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD differ not only with respect to the presence or absence of flagella and amounts of OmpF and OmpC but also with respect to the amounts of a number of proteins present in their outer membranes, including CirA and CsgD (see Results and reference 26), which we hypothesize results in E. coli MG1655 mot-1 having a higher affinity than E. coli MG1655 ⌬flhD for the E. coli binding sites on the mixed biofilms they inhabit. In addition, E. coli MG1655 mot-1 grows slower than E. coli MG1655 ⌬flhD on a number of sugars present in mucus and in mouse cecal mucus in vitro (Table 5) . Accordingly, we suggest that the lower growth rate of E. coli MG1655 mot-1 within a biofilm is compensated for by its higher affinity for the biofilm. If so, it would then be expected that if E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD were fed to mice in equal numbers they would cocolonize in about equal numbers, as observed (Fig. 3B) , and if mice were fed E. coli MG1655 mot-1 and E. coli MG1655 ⌬flhD at a ratio of 10 5 :1, that ratio would also be maintained throughout the duration of the experiment, as observed ( Fig. 4A ). However, it would also be expected that if mice were fed E. coli MG1655 ⌬flhD and E. coli MG1655 mot-1 at a ratio of 10 5 :1, that ratio would be maintained throughout the duration of the experiment, when in fact, under these conditions, low numbers of E. coli MG1655 mot-1 grow to higher numbers (Fig. 5A ). This can be explained if E. coli MG1655 mot-1 also grows in a second niche that E. coli MG1655 ⌬flhD cannot colonize or colonizes poorly. That second niche could be another mixed biofilm consisting of a different group of anaerobes in which E. coli MG1655 mot-1 takes advantage not only of its higher affinity for binding sites but also of its superior growth rate on galactose and thereby prevents E. coli MG1655 ⌬flhD from occupying that niche. Alternatively, that second niche could be another mixed biofilm that contains an anaerobe that makes a bacteriocin that inhibits E. coli MG1655 ⌬flhD growth far more than it inhibits E. coli MG1655 mot-1 growth, much in the same way that E. coli MG1655 ⌬flhD is more sensitive to colicin V than E. coli MG1655 mot-1. Most bacterial species, including several that reside in the mammalian intestine, are known to make bacteriocins, many of which kill across species (54) . Finally, our hypothesis raises the possibility that E. coli strains with vastly different surfaces (e.g., fimbriae, O, K, and H antigens etc) reside in biofilms made up of different anaerobes that supply different sugars to those strains, which could explain why different E. coli strains display different nutritional programs in the intestine (19, 35) . Whether our hypothesis, which we call the "Restaurant" hypothesis, has merit will be the focus of future research.
